North Annette 4
4 · Turning Point Therapeutics, Inc. · Filed Aug 31, 2021
Insider Transaction Report
Form 4
North Annette
EVP, General Counsel & Secty.
Transactions
- Exercise/Conversion
Common Stock
2021-08-30$17.00/sh+10,000$170,000→ 22,365 total - Sale
Common Stock
2021-08-30$80.00/sh−10,000$800,000→ 12,365 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-30−10,000→ 144,609 totalExercise: $17.00Exp: 2029-04-14→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020.
- [F2]One-fourth of the option vested on April 15, 2020. Thereafter, 1/48th of the Option vests on a monthly basis over 36 months until the option becomes fully vested.